Newsfeeds - Spark Newswire

2 minute read

News

TCR² Therapeutics Announces 2022 Strategic Priorities And Anticipated Milestones

Today, 5:51 PM

TCR2 Therapeutics Inc. (NASDAQ:TCRR), a clinical-stage cell therapy company with a pipeline of novel T cell therapies for cancer patients suffering from solid tumors, today announced its strategic priorities and

TCRR

32 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 5:51 PM

On Thursday, 615 stocks hit new 52-week lows.

AAOI

1 minute read

SVB Leerink Maintains Market Perform on TCR2 Therapeutics, Lowers Price Target to $7

By Benzinga Newsdesk

Today, 5:51 PM

SVB Leerink analyst Jonathan Chang maintains TCR2 Therapeutics (NASDAQ:TCRR) with a Market Perform and lowers the price target from $8 to $7.

TCRR

1 minute read

10 Biggest Price Target Changes For Thursday

By Lisa Levin

Today, 5:51 PM

Wedbush boosted Tesla, Inc. (NASDAQ: TSLA) price target from $1,000 to $1,100. Tesla shares fell 1.4% to $853.67 in pre-market trading.

ABT

1 minute read

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

Today, 5:51 PM

APEN

8 minute read

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs

By Shanthi Rexaline

Today, 5:51 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7)

ABIO

7 minute read

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results

By Shanthi Rexaline

Today, 5:51 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6)

ADVM

6 minute read

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout

By Shanthi Rexaline

Today, 5:51 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4)

ADTX

5 minute read

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO

By Shanthi Rexaline

Today, 5:51 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 30)

ADMA

7 minute read

The Daily Biotech Pulse: AbbVie’s Migraine Drug OK’d By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug

By Shanthi Rexaline

Today, 5:51 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 28)

ABBV